Vanguard Plus 5

Description: Vanguard Plus 5 contains attenuated strains of CD virus CAV-2 CPI virus and CPV propagated on an established canine cell line. The CPV fraction is high titer (107.0 TCID50/dose) and was attenuated by low passage (35 passes from the canine isolate with a maximum of 2 additional passes allowed for production) on the canine cell line which gives it the immunogenic properties capable of overriding maternal antibody interference. Some puppies in the field may have higher levels of maternal antibodies than those evaluated in our pivotal efficacy study. Vanguard Plus 5 is packaged in freeze-dried form with inert gas in place of vacuum.
Contains penicillin and streptomycin as preservatives.
Indications: Vanguard Plus 5 is for vaccination of healthy dogs 6 weeks of age or older as an aid in preventing canine distemper caused by canine distemper (CD) virus infectious canine hepatitis (ICH) caused by canine adenovirus type 1 (CAV-1) respiratory disease caused by canine adenovirus type 2 (CAV-2) canine parainfluenza caused by canine parainfluenza (CPI) virus and canine parvoviral enteritis caused by canine parvovirus (CPV).
Directions:
1. General Directions: Vaccination of healthy dogs is recommended. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided shake well and administer 1 mL subcutaneously or intramuscularly.
2. Primary Vaccination: Healthy dogs 6 weeks of age or older should receive 3 doses each administered 3 weeks apart.
3. Revaccination: Annual revaccination with a single dose is recommended.
Precaution(s): Store at 2-7C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze.
Use entire contents when first opened.
Sterilized syringes and needles should be used to administer this vaccine. Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine.
Burn containers and all unused contents.
Caution(s): Vaccination of pregnant bitches should be avoided.
As with many vaccines anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease are malnourished or parasitized are stressed due to shipment or environmental conditions are otherwise immunocompromised or the vaccine is not administered in accordance with label directions.
For use in dogs only.